FIBROGEN INC
Total Trades
53
Buys
5
Sells
36
Largest Trade
N/A
Insiders
13
Institutional Funds
5
Inst. Value
$1M+
Activist Filings
20
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Wettig Thane | CEO | BUY | $15K–$50K | 4K | $9.12 | Nov 17, 2025 |
| Schoeneck James A | Director | BUY | $100K–$500K | 24K | $5.07 | Jul 2, 2025 |
| Wettig Thane | CEO | BUY | $50K–$100K | 145K | $0.35 | Mar 25, 2025 |
| Schoeneck James A | Director | BUY | $100K–$500K | 300K | $0.35 | Mar 24, 2025 |
| Adib Deyaa | Chief Medical Offi… | BUY | $15K–$50K | 22K | $1.17 | Jun 13, 2024 |
| Henderson Jeffrey William | Director | SELL | $1K–$15K | 2K | $1.03 | Sep 7, 2023 |
| Henderson Jeffrey William | Director | SELL | $1K–$15K | 2K | $1.91 | Aug 8, 2023 |
| Henderson Jeffrey William | Director | SELL | $1K–$15K | 2K | $2.69 | Jul 14, 2023 |
| Conterno Enrique A | CEO | SELL | $1K–$15K | 2K | $2.80 | Jul 10, 2023 |
| Wettig Thane | Chief Commercial O… | SELL | $1K–$15K | 791 | $16.53 | Jun 26, 2023 |
| Chung Christine | SVP | SELL | $100K–$500K | 13K | $17.19 | Jun 16, 2023 |
| Cravatt Benjamin | Director | SELL | $50K–$100K | 4K | $17.17 | Jun 9, 2023 |
| Cravatt Benjamin | Director | GRANT | N/A | 8K | — | Jun 9, 2023 |
| Brennan Aoife | Director | SELL | $50K–$100K | 5K | $17.19 | Jun 9, 2023 |
| Brennan Aoife | Director | GRANT | N/A | 8K | — | Jun 9, 2023 |
| Blaug Suzanne | Director | GRANT | N/A | 8K | — | Jun 9, 2023 |
| Blaug Suzanne | Director | SELL | $100K–$500K | 9K | $17.20 | Jun 9, 2023 |
| Ho Maykin | Director | GRANT | N/A | 8K | — | Jun 9, 2023 |
| Ho Maykin | Director | SELL | $100K–$500K | 9K | $17.44 | Jun 9, 2023 |
| EDWARDS JEFFREY L | Director | GRANT | N/A | 8K | — | Jun 9, 2023 |
| EDWARDS JEFFREY L | Director | SELL | $100K–$500K | 8K | $17.19 | Jun 9, 2023 |
| Henderson Jeffrey William | Director | GRANT | N/A | 8K | — | Jun 9, 2023 |
| Henderson Jeffrey William | Director | SELL | $100K–$500K | 7K | $17.45 | Jun 9, 2023 |
| Schoeneck James A | Director | SELL | $100K–$500K | 7K | $18.03 | Jun 9, 2023 |
| Schoeneck James A | Director | GRANT | N/A | 8K | — | Jun 9, 2023 |
| Wettig Thane | Chief Commercial O… | SELL | $15K–$50K | 2K | $17.04 | Jun 9, 2023 |
| Graham Juan | CFO | SELL | $15K–$50K | 2K | $16.99 | Jun 9, 2023 |
| Chung Christine | SVP | SELL | $50K–$100K | 4K | $17.04 | Jun 9, 2023 |
| Eisner Mark | EVP | SELL | $15K–$50K | 2K | $17.04 | Jun 9, 2023 |
| Conterno Enrique A | CEO | SELL | $100K–$500K | 9K | $17.04 | Jun 9, 2023 |
| Eisner Mark | EVP | SELL | $15K–$50K | 1K | $18.83 | Jun 5, 2023 |
| Conterno Enrique A | CEO | SELL | $15K–$50K | 2K | $19.52 | Apr 11, 2023 |
| Eisner Mark | Chief Medical Offi… | SELL | $100K–$500K | 9K | $18.78 | Apr 6, 2023 |
| Chung Christine | SVP | SELL | $100K–$500K | 7K | $18.78 | Apr 6, 2023 |
| Wettig Thane | Chief Commercial O… | SELL | $15K–$50K | 905 | $18.71 | Mar 25, 2023 |
| Chung Christine | SVP | SELL | $100K–$500K | 16K | $20.70 | Mar 11, 2023 |
| Chung Christine | SVP | GRANT | N/A | 15K | — | Mar 11, 2023 |
| Conterno Enrique A | CEO | GRANT | N/A | 60K | — | Mar 11, 2023 |
| Conterno Enrique A | CEO | SELL | $1M+ | 56K | $20.62 | Mar 11, 2023 |
| Eisner Mark | Chief Medical Offi… | SELL | $100K–$500K | 18K | $20.60 | Mar 11, 2023 |
| Eisner Mark | Chief Medical Offi… | GRANT | N/A | 20K | — | Mar 11, 2023 |
| Graham Juan | CFO | GRANT | N/A | 8K | — | Mar 11, 2023 |
| Graham Juan | CFO | SELL | $100K–$500K | 8K | $20.54 | Mar 11, 2023 |
| Wettig Thane | Chief Commercial O… | SELL | $100K–$500K | 14K | $20.63 | Mar 11, 2023 |
| Wettig Thane | Chief Commercial O… | GRANT | N/A | 15K | — | Mar 11, 2023 |
| Eisner Mark | Chief Medical Offi… | SELL | $15K–$50K | 1K | $21.87 | Mar 6, 2023 |
| Conterno Enrique A | CEO | SELL | $15K–$50K | 2K | $19.95 | Jan 10, 2023 |
| Wettig Thane | Chief Commercial O… | SELL | $1K–$15K | 734 | $15.80 | Dec 28, 2022 |
| Graham Juan | CFO | SELL | $50K–$100K | 6K | $14.89 | Dec 15, 2022 |
| Graham Juan | CFO | SELL | $15K–$50K | 2K | $14.64 | Dec 15, 2022 |
Institutional Ownership
13F filings as of Sep 30, 2025 · 5 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 378K | $1M+ | SH |
| CIBC Private Wealth Group LLC | 287 | $1K–$15K | SH |
| JPMORGAN CHASE & CO | 12 | <$1K | SH |
| DANSKE BANK A/S | 1 | <$1K | SH |
| CWM, LLC | 26 | N/A | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · May 15, 2025
8.4%
8.5M shares
SC 13G/A · Feb 14, 2025
6.8%
6.8M shares
SC 13G/A · Feb 13, 2025
4.6%
4.6M shares
SC 13G/A · Nov 14, 2024
6.8%
6.8M shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Nov 12, 2024
9.9%
9.9M shares
SC 13G/A · Nov 12, 2024
5.8%
5.9M shares
SC 13G/A · Nov 4, 2024
5.8%
5.9M shares
SC 13G/A · Nov 4, 2024
5.8%
5.9M shares
SC 13G/A · Jul 8, 2024
2.4%
2.4M shares
SC 13G · Feb 14, 2024
9.9%
9.8M shares
Point72 Asset Management, L.P.
SC 13G/A · Feb 14, 2024
1.6%
1.6M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
7.2%
7.0M shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Feb 12, 2024
14.7%
14.5M shares
SC 13G/A · Jan 26, 2024
7.3%
7.2M shares
SC 13G · Jul 19, 2023
4.7%
4.6M shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Feb 9, 2023
14.8%
13.9M shares
The Vanguard Group - 23-1945930
SC 13G/A · Mar 9, 2022
10.1%
9.4M shares
PRIMECAP Management Company 95-3868081
SC 13G/A · Feb 10, 2022
14.0%
13.0M shares
SC 13G/A · Feb 1, 2022
7.2%
6.6M shares
SC 13G · Jan 28, 2022
5.7%
5.3M shares